Cytoskeletal Tropomyosin as a Biomarker in Clostridium difficile Infection.

Conclusion: Tpm has a potential role as a CDI biomarker in combination with C. difficile PCR and an appropriate clinical evaluation. However, non-muscle Tpm, as a biomarker for CDI, suffers from a low sensitivity in our study. Therefore further investigation using larger cohorts is needed.
PMID: 30701001 [PubMed]

Source: Clin Med Res - February 1, 2019 Category: Research Authors: Usacheva EA, Peterson LR, Mendoza K, Schora DM, Hossain MM, Jin JP Tags: J Clin Med Res Source Type: research